{"id":5628,"date":"2026-01-30T03:33:03","date_gmt":"2026-01-30T03:33:03","guid":{"rendered":"https:\/\/bihavadis.com\/?p=5628"},"modified":"2026-01-30T03:33:03","modified_gmt":"2026-01-30T03:33:03","slug":"her-hastaya-ayni-ilac-devri-bitti-kanserle-mucadelede-savasci-hucreler-donemi","status":"publish","type":"post","link":"https:\/\/bihavadis.com\/index.php\/2026\/01\/30\/her-hastaya-ayni-ilac-devri-bitti-kanserle-mucadelede-savasci-hucreler-donemi\/","title":{"rendered":"Her Hastaya Ayn\u0131 \u0130la\u00e7 Devri Bitti: Kanserle M\u00fccadelede Sava\u015f\u00e7\u0131 H\u00fccreler D\u00f6nemi"},"content":{"rendered":"

Kanserle m\u00fccadelede dengeleri de\u011fi\u015ftiren yeni bir d\u00f6nem ya\u015fan\u0131yor. Bilim insanlar\u0131 art\u0131k kanseri yaln\u0131zca d\u0131\u015far\u0131dan verilen ila\u00e7larla de\u011fil, v\u00fccudun do\u011fu\u015ftan gelen savunma g\u00fcc\u00fc olan ba\u011f\u0131\u015f\u0131kl\u0131k sistemini kullanarak yenmeyi hedefliyor. D\u00fcnya genelinde her y\u0131l yakla\u015f\u0131k 20 milyon yeni kanser vakas\u0131 tan\u0131 al\u0131rken, 10 milyona yak\u0131n insan da kanser y\u00fcz\u00fcnden ya\u015fam\u0131n\u0131 kaybediyor. T\u00fcrkiye\u2019de ise y\u0131lda 240 bini a\u015fk\u0131n yeni vaka bildiriliyor. Bu tabloya ra\u011fmen umut veren geli\u015fmeler h\u0131z kazan\u0131yor. \u00d6zellikle ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin en etkili sava\u015f\u00e7\u0131lar\u0131 aras\u0131nda yer alan NK (Natural Killer – Do\u011fal \u00d6ld\u00fcr\u00fcc\u00fc) h\u00fccrelerine dayal\u0131 h\u00fccresel imm\u00fcnoterapiler, kanser tedavisinde ezberleri bozuyor.<\/strong><\/em><\/p>\n

Ac\u0131badem \u00dcniversitesi Molek\u00fcler Biyoloji ve Genetik B\u00f6l\u00fcm\u00fc \u00d6\u011fretim \u00dcyesi Dr. Tolga S\u00fctl\u00fc, bu alandaki \u00e7al\u0131\u015fmalar\u0131yla, \u201ckanseri kendi h\u00fccrelerimizle yok etme\u201d fikrini bilimsel ger\u00e7ekli\u011fe d\u00f6n\u00fc\u015ft\u00fcrmeyi ama\u00e7l\u0131yor.<\/strong><\/em><\/p>\n

NK h\u00fccreleri, ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin do\u011fu\u015ftan gelen ve h\u0131zl\u0131 tepki veren h\u00fccreleri olarak tan\u0131mlan\u0131yor. NK h\u00fccrelerinin kanserle sava\u015fta \u00f6nemli rol oynad\u0131klar\u0131n\u0131 vurgulayan Dr. Tolga S\u00fctl\u00fc, \u201cNK h\u00fccreleri, v\u00fccutta anormalle\u015fmi\u015f ya da kanserle\u015fmi\u015f h\u00fccreleri \u00f6nceden e\u011fitilmeye gerek duymadan tan\u0131yabilen \u2018katil h\u00fccrelerdir\u2019. Bu \u00f6zellikleri sayesinde NK h\u00fccreleri, \u00f6zellikle kanserin erken yay\u0131l\u0131m\u0131n\u0131 ve n\u00fcksleri \u00f6nlemede b\u00fcy\u00fck potansiyel ta\u015f\u0131yor\u201d diyor.\u00a0<\/p>\n

Kanserde \u201cHer Hastaya Ayn\u0131 \u0130la\u00e7\u201d D\u00f6nemi Kapand\u0131\u00a0<\/strong><\/p>\n

Geleneksel kemoterapi ve radyoterapi y\u00f6ntemlerinin yerini giderek daha fazla imm\u00fcnoterapiler al\u0131yor.\u00a0\u0130mm\u00fcnoterapi, ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin kanser\u00a0<\/strong>h\u00fccrelerini tan\u0131ma ve yok etme kapasitesini g\u00fc\u00e7lendirmeyi ama\u00e7layan tedavilerin genel ad\u0131 olarak tan\u0131mlan\u0131yor. Bu y\u00f6ntemde, do\u011frudan kanser h\u00fccresini hedefleyecek ila\u00e7lar kullanmak yerine, v\u00fccudun kendi savunma mekanizmalar\u0131 yeniden devreye sokuluyor. Ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin hedefe y\u00f6nelik tepki verebilme \u00f6zelli\u011fi sayesinde sa\u011fl\u0131kl\u0131 h\u00fccreler m\u00fcmk\u00fcn oldu\u011funca korunurken, kanser h\u00fccreleri hedef al\u0131nabiliyor. G\u00fcn\u00fcm\u00fczde en s\u0131kl\u0131kla kullan\u0131lan klinik uygulamalar, ba\u011f\u0131\u015f\u0131kl\u0131k sistemini harekete ge\u00e7irecek antikor veya sitokin gibi molek\u00fcllerin hastaya verilmesine dayansa da,\u00a0imm\u00fcnoterapi alan\u0131ndaki en \u00e7arp\u0131c\u0131 geli\u015fmeler, ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinin bizzat tedavinin kendisi haline geldi\u011fi h\u00fccresel imm\u00fcnoterapiler\u00a0olarak \u00f6ne \u00e7\u0131k\u0131yor.\u00a0<\/p>\n

Bu yakla\u015f\u0131m\u0131n, kanser tedavisini tamamen ki\u015fiye \u00f6zel hale getirebildi\u011fine de dikkat \u00e7eken Dr. Tolga S\u00fctl\u00fc, \u201cArt\u0131k ba\u011f\u0131\u015f\u0131kl\u0131k sistemini sadece uyarm\u0131yoruz, onu do\u011frudan y\u00f6nlendiriyoruz. Hastan\u0131n kendi NK h\u00fccrelerini veya T h\u00fccrelerini al\u0131yoruz, genetik olarak kanseri hedefleyebilecek \u015fekilde yeniden programl\u0131yoruz ve tekrar hastaya veriyoruz. Bu h\u00fccreler de do\u011frudan kanser h\u00fccrelerini hedef alarak onlar\u0131 yok ediyorlar. Bu, her hasta i\u00e7in \u00f6zel olarak tasarlanabilen bir tedavi\u201d \u015feklinde konu\u015fuyor.\u00a0<\/p>\n

NK h\u00fccre temelli tedavilerde s\u00fcre\u00e7, hastan\u0131n kendi ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccreleriyle ba\u015fl\u0131yor. Bu h\u00fccreler \u00f6zel GMP laboratuvarlar\u0131nda \u00e7o\u011falt\u0131l\u0131yor ve kanser h\u00fccrelerini daha etkili tan\u0131yacak \u015fekilde yeniden programlan\u0131yor. Bu y\u00f6n\u00fcyle h\u00fccresel imm\u00fcnoterapiler, \u2018her hastaya ayn\u0131 ila\u00e7\u2019 d\u00f6neminin kapand\u0131\u011f\u0131n\u0131n en somut g\u00f6stergesi olarak kabul ediliyor.<\/p>\n

NK H\u00fccreleri Uzun Y\u0131llar V\u00fccutta Kansere Kar\u015f\u0131 Sava\u015f\u0131yor<\/strong><\/p>\n

Antikor bazl\u0131 tedaviler belirli bir s\u00fcre sonra v\u00fccuttan temizlenirken, h\u00fccresel tedaviler \u00e7ok daha kal\u0131c\u0131 etkiler g\u00f6sterebiliyor. \u201cAntikorlar birka\u00e7 hafta i\u00e7inde etkisini kaybeder ve tekrar tekrar uygulanmas\u0131 gerekir. Ancak ba\u011f\u0131\u015f\u0131kl\u0131k sistemi h\u00fccreleri, v\u00fccutta uzun s\u00fcre kalabilir ve kanser h\u00fccrelerini aktif olarak aramaya devam eder. Bu h\u00fccreler, kansere kar\u015f\u0131 \u00f6m\u00fcr boyu sava\u015facak \u015fekilde programlan\u0131yor. Bug\u00fcn d\u00fcnyada, 10\u201320 y\u0131l \u00f6nce h\u00fccresel imm\u00fcnoterapi alm\u0131\u015f ve hastal\u0131\u011f\u0131 kontrol alt\u0131nda olan hastalar var\u201d diyen Dr. Tolga S\u00fctl\u00fc, h\u00fccresel tedavilerin uzun vadeli koruma potansiyeline dikkat \u00e7ekiyor.<\/p>\n

Peki NK h\u00fccre temelli h\u00fccresel imm\u00fcnoterapiler \u00f6zellikle hangi kanserlerde etkili? Bu tedavinin \u00f6zellikle l\u00f6semi, lenfoma, multiple miyelom gibi hematolojik kanserlerde y\u00fcksek ba\u015far\u0131 oranlar\u0131 g\u00f6sterdi\u011fini s\u00f6yleyen Dr. Tolga S\u00fctl\u00fc, \u201cAncak geli\u015fmeler bununla s\u0131n\u0131rl\u0131 de\u011fil. Meme, akci\u011fer ve kolon kanseri gibi solid t\u00fcm\u00f6rlerde de NK h\u00fccreleriyle ilgili y\u00fczlerce klinik \u00e7al\u0131\u015fma y\u00fcr\u00fct\u00fcl\u00fcyor. \u00d6n\u00fcm\u00fczdeki y\u0131llarda bu alanda da onayl\u0131 tedavileri g\u00f6rece\u011fiz\u201d \u015feklinde solid t\u00fcm\u00f6rler i\u00e7in de umutlu konu\u015fuyor.<\/p>\n

Yapay Zeka ile NK H\u00fccreleri Daha Ak\u0131ll\u0131 Hale Geliyor<\/strong><\/p>\n

T\u00fcrkiye\u2019de CAR-T h\u00fccreleri ve NK h\u00fccreleriyle h\u00fccresel imm\u00fcnoterapi alan\u0131nda \u00e7al\u0131\u015fma yapan, s\u0131n\u0131rl\u0131 say\u0131da merkez bulunuyor. Ac\u0131badem \u00dcniversitesi\u2019nin bu alanda y\u00fcr\u00fctt\u00fc\u011f\u00fc \u00e7al\u0131\u015fmalarla \u00f6ne \u00e7\u0131kt\u0131\u011f\u0131n\u0131 vurgulayan Dr. Tolga S\u00fctl\u00fc, malign melanom (deri kanseri), l\u00f6semi, lenfoma ba\u015fta olmak \u00fczere bir\u00e7ok kanser t\u00fcr\u00fcnde NK h\u00fccrelerini merkeze alan yenilik\u00e7i tedaviler \u00fczerinde \u00e7al\u0131\u015ft\u0131klar\u0131na dikkat \u00e7ekiyor.\u00a0<\/p>\n

Ayr\u0131ca geli\u015fmi\u015f DNA analizleri ve yapay zeka destekli veri i\u015fleme y\u00f6ntemleri sayesinde, NK h\u00fccrelerinin hangi hastada daha etkili olaca\u011f\u0131 art\u0131k daha do\u011fru \u00f6ng\u00f6r\u00fclebiliyor. \u201cYapay zeka, ki\u015fiye \u00f6zel h\u00fccresel tedavilerin geli\u015ftirilmesini h\u0131zland\u0131r\u0131yor. Art\u0131k kanser olan herkese ayn\u0131 yakla\u015f\u0131m\u0131 uygulam\u0131yoruz\u201d
\u00a0diyen Dr. Tolga S\u00fctl\u00fc, gelece\u011fin onkolojisinin ki\u015fiselle\u015ftirilmi\u015f h\u00fccresel tedaviler \u00fczerine kurulaca\u011f\u0131n\u0131 vurguluyor. Dr. Tolga S\u00fctl\u00fc\u2019ye g\u00f6re NK h\u00fccreleriyle y\u00fcr\u00fct\u00fclen \u00e7al\u0131\u015fmalar, kanseri v\u00fccudun kendi g\u00fcc\u00fcyle durdurman\u0131n m\u00fcmk\u00fcn olabilece\u011fini g\u00f6steriyor.\u00a0<\/p>\n

\u00a0<\/p>\n

Kaynak: (BYZHA) Beyaz Haber Ajans\u0131<\/p>\n","protected":false},"excerpt":{"rendered":"

Kanserle m\u00fccadelede dengeleri de\u011fi\u015ftiren yeni bir d\u00f6nem ya\u015fan\u0131yor. Bilim insanlar\u0131 art\u0131k kanseri yaln\u0131zca d\u0131\u015far\u0131dan verilen ila\u00e7larla de\u011fil, v\u00fccudun do\u011fu\u015ftan gelen savunma g\u00fcc\u00fc olan ba\u011f\u0131\u015f\u0131kl\u0131k sistemini kullanarak yenmeyi hedefliyor.<\/p>\n","protected":false},"author":1,"featured_media":5629,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[382,1315,467,571,1314],"class_list":["post-5628","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-alan","tag-bagisiklik-sistemini","tag-hasta","tag-kanser","tag-tedaviler"],"_links":{"self":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/5628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/comments?post=5628"}],"version-history":[{"count":1,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/5628\/revisions"}],"predecessor-version":[{"id":5630,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/5628\/revisions\/5630"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/media\/5629"}],"wp:attachment":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/media?parent=5628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/categories?post=5628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/tags?post=5628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}